Plutonium- or americium-induced liver tumors and lesions in beagles.
Plutonium-239 or 241Am administered intravenously in the monomeric citrate form was initially deposited in beagle livers principally in the hepatocytes and to a much lesser extent in the sinusoidal macrophages and connective tissues. The initial distribution was quite uniform throughout the hepatic parenchyma; however, at later postinjection intervals, depending on the amount of injected activity, the liver burden became increasingly more focal due to: (1) a progressive shift of the radionuclide from the hepatic epithelium to the macrophages; (2) the movement of such macrophages toward the portal or central regions of the lobule; and (3) the displacement of the older more radioactive tissue by regenerating hepatocytes, which generally have a much lower radionuclide content. The hepatic lesions produced by Pu or Am included: (1) necrosis and degenerative changes that were clinically serious or fatal in some of the animals injected with approximately 107 kBq kg-1; (2) marked structural and circulatory changes resulting from necrosis and focal hepatocyte hyperplasia; (3) a significant incidence of both benign and malignant primary liver tumors. In both Pu- and Am-treated dogs, the most frequently appearing neoplasm was the bile duct adenoma, followed by the cholangiocarcinoma. The most obvious difference between Pu- and Am-induced liver neoplasia was the greater frequency of fibrosarcomas and mast cell sarcomas in the Am-treated groups. Hepatomas were of relatively low frequency in animals with Pu or Am burdens. Although the incidence of bone neoplasia was high among the dogs in these studies, the risk of liver tumors, especially in the Am-treated animals, exceeded that of the skeleton in some of the lower dosage levels where the survival times were long. A risk coefficient of approximately 1200 fatal liver malignancies (10(4) beagle Gy)-1, derived from the dosage groups with long survival times, was calculated for combined Pu and Am animals. The prominence of the liver syndromes in beagles with burdens of Pu or Am indicates that humans with body burdens of 239Pu, 241Am, or other actinide elements may be at risk from radiation effects in the liver, including neoplasia development.
Taylor
G N
GN
Radiobiology Division, University of Utah, Salt Lake City 84112.
Lloyd
R D
RD
Mays
C W
CW
Angus
W
W
Miller
S C
SC
Shabestari
L
L
Hahn
F F
FF
D000236:Adenoma / Q000209:etiology; D000576:Americium / Q000008:administration & dosage; D000818:Animals; D001650:Bile Duct Neoplasms / Q000209:etiology; D001859:Bone Neoplasms / Q000209:etiology; D004285:Dogs; D007275:Injections, Intravenous; D008113:Liver Neoplasms / Q000209:etiology*; D009381:Neoplasms, Radiation-Induced; D011005:Plutonium / Q000008:administration & dosage
D011005:Plutonium; D000576:Americium